Moreover, miR-128 regulates the infiltration of antitumor immune cells, including dendritic cells (DCs), CD8 + T cells, and NKT cells, in the immune microenvironment via the ZEB1/CD47 axis and epithelial-mesenchymal transition, ultimately inhibiting pancreatic cancer growth and metastasis [13]. The gene discussed is CD8A; the disease is pancreatic neoplasm.